MENU
TIL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Instil Bio (TIL) Ownership - Who owns Instil Bio?

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer... Show more

Profile

Industry
Precious Metals
Address
3963 Maple Avenue
Phone
+1 972 499-3350
Employees
49
Web
https://www.instilbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
53.78M
P/E Ratio
N/A
Total Cash
79.67M
Projected Growth
N/A
Total Debt
84.92M
Revenue
N/A
Risk (Beta)
1.92
Dividend Yield
N/A
Total Cash/Share
11.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
TIL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company engaged in the reinsurance business

Industry Biotechnology

Profile
Details
Industry
Precious Metals
Address
3963 Maple Avenue
Phone
+1 972 499-3350
Employees
49
Web
https://www.instilbio.com